Which of the following statements is/are TRUE ABOUT Spravato? [Select ALL THAT APPLY]. a. It is indicated for the treatment of treatment-resistant depression. b. Lketamine is its active ingredient. c. It is a schedule IV controlled substance. d. It is a non-competitive N-methyl D-aspartate (NMDA) receptor antagonist. e. It is available as a nasal spray.

Kesimpta (Ofatumumab) is indicated for the treatment of: a. Hypertension b. Gout c. Multiple sclerosis d. Type II diabetes e. Parkinsonism

Which of the following glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) is administered subcutaneously once daily? [Select ALL THAT APPLY]. a. Byetta b. Adlyxin c. Victoza d. Trulicity e. Tanzeum

Which of the following statements is/are TRUE ABOUT Winlevi? [Select ALL THAT APPLY]. a. The active ingredient is Clascoterone. b. It is an estrogen receptor inhibitor. c. Indicated for the treatment of acne vulgaris. d. It should only be used in patients 12 years of age or younger. e. It is available as topical gel.

What is the principal advantage of Olinvyk, a newly approved opioid pain reliever, over available other opioid analgesics? a. Cheap b. Less chance of abuse c. no dosage adjustments in patients with renal impairment d. does not cause fatal respiratory depression e. more patient compliance due to its oral dosage form

Who developed a Pharmacy Toolkit to help pharmacists engage and educate patients about the safe use, storage, and disposal of pain medicines? a. CDC b. CMSA c. ASHP d. AAOA e. FTC

The FDA has recently approved Xywav for the treatment of cataplexy or excessive daytime sleepiness (EDS) in patients 7 years of age and older with narcolepsy. Another drug Xyrem is available for the same indication in the US. What is a principal advantage of using Xywav over Xyrem? a. Less side effects b. Less potential for abuse c. Low sodium contents d. More potency e. Cheaper

Entresto is indicated for the treatment of: a. Hypertension b. Heart failure c. Depression d. Type II diabetes mellitus e. Panic disorder

Which of the following statements is/are TRUE ABOUT Trulicity? [Select ALL THAT APPLY]. a. The active ingredient is Dulaglutide. b. It is indicated for the treatment of migraine. c. It is a glucagon-like peptide-1 (GLP-1) receptor agonist. d. Initiate at 0.75 mg subcutaneously once weekly. e. Contraindicated in patients with a personal or family history of medullary thyroid carcinoma.

Rexulti (Brexpiprazole) is indicated for: [Select ALL THAT APPLY]. a. OCD b. Schizophrenia c. Hypertension d. Arrhythmia e. Depression